News About: Pharm. Industry
Dongwha welcomes new presidentDongwha Pharm said on Thursday it tapped Lee Seung-Rae, former executive director of Pfizer Korea, as new president.
A graduate of Sungkyunkwan University, Lee joined Pfizer ...
|
Celltrion gets green light in EU for antibody drug
Celltrion’s antibody drug Remsima won a final approval from the European Commission, the European Union’s executive arm, the company said Wednesday in its regulatory filing.
Celltrion officials said the EC’s approv...
NovoRapid FlexPen ranks first in fast-acting human insulin pen market
Novo Nordisk’s NovoRapid FlexPen, a unique insulin pen that allows for easy injection, ranked first in the domestic fast-acting human insulin pen market during the second quarter of this year, according to IMS Health ...
Celltrion to build GMP plant in North Chungcheong Province
Celltrion said Wednesday it will become the country’s largest pharmaceutical producer with the establishment of its GMP (Good Manufacturing Practice)-compliant plant in Ochang, Nother Chungcheong Province, the company...
SK Chemicals conducts Phase 3 clinical trial of cell culture influenza vaccine
SK Chemicals said Tuesday that it has carried out Phase 3 clinical tests for its influenza cell culture vaccine using animal cell after it gained the green light from the Ministry of Food and Drug Safety.
According...
Novartis Korea names Moon Hak-sun new Taiwan presidentMoon Hak-sun, a head of Novartis Korea’s oncology division, was named the new president of the company’s Taiwan branch, Novartis Korea said Tuesday. He will take office on Septe...
|
B2Pharm unveils green list alert serviceB2Pharm, the local information provider for pharmaceutical business, said Tuesday it has It “green list alert service” (GLAS) for Korean drug makers.
The GLAS is designed to ...
|
Court to hand down final ruling over Dong-A’s illegal kickbacks
The Seoul Central District Court is expected to make its final ruling on September 30 over seven former and incumbent executives of Dong-A Pharmaceutical for offering 4.8 billion won in bribes to 1,400 doctors as well...
DHP Korea likely to go public in Kosdaq in November
DHP Korea, a local leading artificial tear maker, said Monday that it passed the Korea Exchange’s preliminary evaluation on initial public offerings (IPOs) on August 23. The company is hoping to get listed on the Kosd...
MFDS approves new treatment for advanced colorectal cancer
Bayer HealthCare Pharmaceuticals on Monday gained the green light from the Ministry of Food and Drug Safety (MFDS) on Stivarga (regorafenib) to treat patients with metastatic colorectal cancer (mCRC).
Stivarga is a...
